Regulations, No.: FDISM/FDIC/TRG/001 Rev_3, governing licensing of public and private manufacturers, distributors, wholesalers and retailers of medical Products; (13 page(s), in English)

Extension of the Regulatory Flexibility for Class B, C and D Medical Devices that are Not Included in the List of Registrable Medical Devices Based on FDA Circular No. 2020-001-A entitled "Amendment to Annex A of FDA Circular No. 2020-001 re: Initial Implementation of Administrative Order No. 2018-0002 "Guidelines Governing the Issuance of an Authorization for a Medical Device based on the ASEAN Harmonized Technical Requirements""; (3 page(s), in English)

Amending Schedule V to the Controlled Drugs and Substances Act (Accelerated scheduling of three fentanyl precursor chemicals and carisoprodol) (3 pages, in English and French) Order Amending Schedule V to the Controlled Drugs and Substances Act (Fentanyl Precursors and Carisoprodol) (14 pages in English, 16 pages in French)